INNV-41. PROSPECTIVE SELECTION OF RECURRENT GLIOBLASTOMA PATIENTS FOR TAILORED THERAPIES. RESULTS OF AN INSTITUTIONAL EXPERIENCE

INTRODUCTION: Failure of clinical trials with targeted therapies in glioblastoma (GBM) is probably due to the enrollment of molecularly unselected patients. In preliminary studies, we prospectively selected recurrent GBM patients on the basis of molecular pattern and administered targeted therapy ac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Giorgio D’Alessandris, Quintino, Montano, Nicola, Martini, Maurizio, Cenci, Tonia, Di Bonaventura, Rina, Giordano, Martina, Caccavella, Valerio, Stumpo, Vittorio, Cocomazzi, Alessandra, Lauretti, Liverana, Fernandez, Eduardo, Olivi, Alessandro, Larocca, Luigi, Pallini, Roberto
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Innovations in Patient Care
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847177/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.580
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares